Hcpe, a Potential Immuno-Modulatory Protein from Helicobacter Pylori That Is Dependent on the Disulfide Bond Protein Dsbhp

Total Page:16

File Type:pdf, Size:1020Kb

Hcpe, a Potential Immuno-Modulatory Protein from Helicobacter Pylori That Is Dependent on the Disulfide Bond Protein Dsbhp Western University Scholarship@Western Electronic Thesis and Dissertation Repository 12-10-2014 12:00 AM HcpE, a potential immuno-modulatory protein from Helicobacter pylori that is dependent on the Disulfide bond protein DsbHP Jeff Lester The University of Western Ontario Supervisor Dr. Carole Creuzenet The University of Western Ontario Graduate Program in Microbiology and Immunology A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Science © Jeff Lester 2014 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Bacteriology Commons, Biochemistry Commons, and the Immunology of Infectious Disease Commons Recommended Citation Lester, Jeff, "HcpE, a potential immuno-modulatory protein from Helicobacter pylori that is dependent on the Disulfide bond protein DsbHP" (2014). Electronic Thesis and Dissertation Repository. 2599. https://ir.lib.uwo.ca/etd/2599 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. HcpE, a potential immuno-modulatory protein from Helicobacter pylori that is dependent on the Disulfide bond protein DsbHP (Thesis format: Monograph) By: Jeffrey Lester Graduate program in Microbiology and Immunology A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science School of Graduate and Postdoctoral Studies The University of Western Ontario London, Ontario, Canada © Jeffrey Lester 2014 i ABSTRACT H. pylori is a human gastric pathogen that colonizes ~ 50% of the world’s population. It can cause gastritis, gastric or duodenal ulcers and also gastric cancer. H. pylori produces Helicobacter cysteine rich protein HcpE, a secreted protein which may play a role in virulence. In this study we show that HcpE is secreted in the culture supernatant both as a soluble protein and in association with outer membrane vesicles, and may play a role in the modulation of H. pylori inflammatory responses. We identified that DsbHP is necessary for HcpE production and secretion in H. pylori, and demonstrated DsbHP has DiSulfide Bond (Dsb) forming activity on reduced lysozyme. Furthermore, we demonstrated that DsbHP has a DsbA-type of activity when expressed in E. coli, despite its similarity with DsbG, and that DsbHP is involved in maintaining redox homeostasis in H. pylori. Key words: Helicobacter pylori. Disulfide bonds. Dsb proteins. Helicobacter Cysteine- rich proteins. Protein secretion. ii DEDICATION This thesis is dedicated to my entire family, specifically Jeff, Lorrie, Rachelle and Justin, who have supported me along the way iii ACKNOWLEDGEMENTS I would like to thank my supervisor Dr. Carole Creuzenet for giving me the opportunity to conduct my research in her laboratory. I would also like to extend my thanks to my advisory committee members Dr. David Heinrichs and Dr. Susan Koval for their advice and support throughout my studies. I would also like to thank all of the members of the Creuzenet lab, past and present for your help throughout the duration of my studies. iv Table of Contents Title Page....................................................................................................................................i ABSTRACT ..................................................................................................................................... ii DEDICATION ................................................................................................................................ iii ACKNOWLEDGEMENTS ............................................................................................................ iv Table of Contents ............................................................................................................................. v List of Figures ................................................................................................................................. ix List of Tables .................................................................................................................................. xi List of Abbreviations: .................................................................................................................... xii CHAPTER 1: INTRODUCTION .................................................................................................... 1 1.1 Helicobacter pylori: a human gastric pathogen ....................................................................... 1 1.2 H. pylori virulence mechanisms .............................................................................................. 2 1.2.1 Urease ............................................................................................................................ 3 1.2.2 Flagella ........................................................................................................................... 4 1.2.3 LPS ................................................................................................................................. 5 1.2.4 Toxins ............................................................................................................................ 6 1.2.5 Adhesins ......................................................................................................................... 8 1.3 Protein secretion systems .................................................................................................. 9 1.3.1 Protein secretion in Helicobacter pylori ......................................................................... 9 1.3.2 Sec secretion for the transport of proteins across the inner membrane ........................ 10 1.3.3 Tat-secretion for the transport of proteins across the inner membrane ........................ 13 1.3.4 Protein folding in the periplasm ................................................................................... 14 1.3.5 General secretory pathway for the transport of proteins from the periplasm to the extracellular matrix ...................................................................................................... 15 1.3.6 Direct transport from the cytoplasm to the extracellular environment ........................ 16 1.3.7 Outer membrane vesicle (OMV) mediated secretion................................................... 17 1.4 Disulfide bond proteins ................................................................................................... 18 1.4.1 Pathways of disulfide bond formation ......................................................................... 19 1.4.2 Importance of Dsb proteins in bacterial virulence ....................................................... 22 1.4.3 Dsb proteins in H. pylori .............................................................................................. 23 1.5 Helicobacter cysteine-rich proteins (Hcps) ..................................................................... 24 1.5.1 Sel1-Like Repeats (SLR), the structural components of Hcp proteins ........................ 27 v 1.5.2 Helicobacter-cysteine rich protein E (HcpE) ............................................................... 29 1.5.3 Putative function of Hcp proteins ................................................................................ 34 1.6 Animal models for studying H. pylori colonization ........................................................ 39 1.7 Hypotheses and objectives .............................................................................................. 41 CHAPTER 2: MATERIALS AND METHODS ........................................................................... 42 2.1 Bacterial strains, growth conditions, and reagents................................................................. 42 2.2 SDS-PAGE and Western blot analysis .................................................................................. 43 2.3 Transformation of E. coli competent cells ............................................................................. 46 2.4 Cloning DsbHP-Flag-His in a pET30a vector for over-expression ......................................... 46 2.5 Cloning an expression vector containing both DsbHP and HcpE ........................................... 47 2.6 Construction of vectors expressing E. coli DsbA-Flag-His and DsbG-Flag-His .................. 47 2.7 Over-expression and purification of proteins via nickel chromatography ............................. 47 2.8 Protein quantification using the Bio-Rad Bradford protein assay ......................................... 50 2.9 Solubility assay for expression of HcpE ................................................................................ 51 2.10 Construction of the H. pylori dsbHP knockout mutant ........................................................... 51 2.11 PCR screening of the dsbHP::kan knockout mutagenesis clones ........................................... 52 2.12 Analyzing H. pylori for detection of HcpE ............................................................................ 53 2.13 OMV preparation and analysis .............................................................................................. 54 2.14 Urease activity assay to assess cellular lysis of H. pylori cultures ........................................ 54 2.15 Cell fractionation of H. pylori...............................................................................................
Recommended publications
  • Review: Other Helicobacter Species
    DOI: 10.1111/hel.12645 SUPPLEMENT ARTICLE Review: Other Helicobacter species Armelle Ménard1 | Annemieke Smet2 1INSERM, UMR1053, Bordeaux Research in Translational Oncology, BaRITOn, Université Abstract de Bordeaux, Bordeaux, France This article is a review of the most important, accessible, and relevant literature pub‐ 2 Laboratorium of Experimental lished between April 2018 and April 2019 in the field of Helicobacter species other than Medicine and Pediatrics, Department of Translational Research in Immunology and Helicobacter pylori. The initial part of the review covers new insights regarding the pres‐ Inflammation, Faculty of Medicine and ence of gastric and enterohepatic non‐H. pylori Helicobacter species (NHPH) in humans Health Sciences, University of Antwerp, Wilrijk (Antwerp), Belgium and animals, while the subsequent section focuses on the progress in our understand‐ ing of the pathogenicity and evolution of these species. Over the last year, relatively Correspondence Armelle Ménard, Laboratoire de few cases of gastric NHPH infections in humans were published, with most NHPH in‐ Bactériologie, INSERM U1053, Campus de fections being attributed to enterohepatic Helicobacters. A novel species, designated Carreire, Université de Bordeaux, Bâtiment 2B RDC ‐ Case 76, 146 rue Léo Saignat, “Helicobacter caesarodunensis,” was isolated from the blood of a febrile patient and F33076 Bordeaux, France. numerous cases of human Helicobacter cinaedi infections underlined this species as a Email: Armelle.Menard@u‐bordeaux.fr true emerging pathogen. With regard to NHPH in animals, canine/feline gastric NHPH cause little or no harm in their natural host; however they can become opportunistic when translocated to the hepatobiliary tract. The role of enterohepatic Helicobacter species in colorectal tumors in pets has also been highlighted.
    [Show full text]
  • Potential of Bacterial Cellulose Chemisorbed with Anti-Metabolites, 3-Bromopyruvate Or Sertraline, to Fight Against Helicobacter Pylori Lawn Biofilm
    International Journal of Molecular Sciences Article Potential of Bacterial Cellulose Chemisorbed with Anti-Metabolites, 3-Bromopyruvate or Sertraline, to Fight against Helicobacter pylori Lawn Biofilm Paweł Krzy˙zek 1,* , Gra˙zynaGo´sciniak 1 , Karol Fijałkowski 2 , Paweł Migdał 3 , Mariusz Dziadas 4 , Artur Owczarek 5 , Joanna Czajkowska 6, Olga Aniołek 7 and Adam Junka 8 1 Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland; [email protected] 2 Department of Immunology, Microbiology and Physiological Chemistry, Faculty of Biotechnology and Animal Husbandry, West Pomeranian University of Technology in Szczecin, 70-311 Szczecin, Poland; karol.fi[email protected] 3 Department of Environment, Hygiene and Animal Welfare, Wroclaw University of Environmental and Life Sciences, 51-630 Wroclaw, Poland; [email protected] 4 Faculty of Chemistry, University of Wroclaw, 50-353 Wroclaw, Poland; [email protected] 5 Department of Drug Form Technology, Wroclaw Medical University, 50-556 Wroclaw, Poland; [email protected] 6 Laboratory of Microbiology, Polish Center for Technology Development PORT, 54-066 Wroclaw, Poland; [email protected] 7 Faculty of Medicine, Lazarski University, 02-662 Warsaw, Poland; [email protected] 8 Department of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, 50-556 Wroclaw, Poland; [email protected] * Correspondence: [email protected] Received: 23 November 2020; Accepted: 11 December 2020; Published: 14 December 2020 Abstract: Helicobacter pylori is a bacterium known mainly of its ability to cause persistent inflammations of the human stomach, resulting in peptic ulcer diseases and gastric cancers. Continuous exposure of this bacterium to antibiotics has resulted in high detection of multidrug-resistant strains and difficulties in obtaining a therapeutic effect.
    [Show full text]
  • Gastroenteritis and Transmission of Helicobacter Pylori Infection in Households1 Sharon Perry,* Maria De La Luz Sanchez,* Shufang Yang,* Thomas D
    Gastroenteritis and Transmission of Helicobacter pylori Infection in Households1 Sharon Perry,* Maria de la Luz Sanchez,* Shufang Yang,* Thomas D. Haggerty,* Philip Hurst,† Guillermo Perez-Perez,‡ and Julie Parsonnet* The mode of transmission of Helicobacter pylori gastrointestinal infections, infection is associated with infection is poorly characterized. In northern California, conditions of crowding and poor hygiene (7,8) and with 2,752 household members were tested for H. pylori infec- intrafamilial clustering (9–12). The organism has been tion in serum or stool at a baseline visit and 3 months later. recovered most reliably from vomitus and from stools dur- Among 1,752 person considered uninfected at baseline, ing rapid gastrointestinal transit (13). These findings raise 30 new infections (7 definite, 7 probable, and 16 possible) occurred, for an annual incidence of 7% overall and 21% the hypothesis that gastroenteritis episodes provide the in children <2 years of age. Exposure to an infected opportunity for H. pylori transmission. household member with gastroenteritis was associated Household transmission of gastroenteritis is common in with a 4.8-fold (95% confidence interval [CI] 1.4–17.1) the United States, particularly in homes with small chil- increased risk for definite or probable new infection, with dren (14). If H. pylori is transmitted person to person, one vomiting a greater risk factor (adjusted odds ratio [AOR] might expect rates of new infection to be elevated after 6.3, CI 1.6–24.5) than diarrhea only (AOR 3.0, p = 0.65). exposure to persons with H. pylori–infected cases of gas- Of probable or definite new infections, 75% were attributa- troenteritis.
    [Show full text]
  • 1 Is Helicobacter Pylori Good for You?
    University of Maryland School of Medicine A Third Century Is Helicobacter pylori Good for You? To Treat or Not to Treat, That is the Question Steven J. Czinn, M.D. Professor and Chair University of Maryland School of Medicine Department of Pediatrics Baltimore, Maryland America’s Oldest Public Medical School - USA Where Discovery Transforms Medicine Learning Objectives Disclosure • To demonstrate that H. pylori is responsible In the past 12 months, I have had no relevant for a significant portion of gastroduodenal financial relationships with the disease. manufacturer(s) of any commercial product(s) • To understand how the host immune response and/or provider(s) of commercial services contributes to Helicobacter associated discussed in this CME activity. disease. • To understand how the host immune response to Helicobacter infection might prevent asthma. • To understand which patient populations should be treated. H. pylori is an Important Human Pathogen World-Wide Prevalence of H. pylori • H. pylori is a gram negative microaerophilic bacterium that selectively colonizes the stomach. 70% 80% • It infects about 50% of the world’s population. 30% 70% 30% 50% • It is classically considered a non-invasive organism, 40% 50% 70% 70% • There is a vigorous innate and adaptive immune 70% 90% response and inflammation that is Th1 predominant 70% and includes (chronic) lymphocyte and (active) 90% 80% 80% 70% neutrophil components. 20% • Despite this response the bacterium generally persists for the life of the host. Marshall, 1995 JAMA 274:1064 1 Natural History of H. pylori infection Eradicating H. pylori Treats or Prevents: Colon Gastric cancer??? Initial infection (in childhood) Adenocarcinoma Nonulcer Chronic gastritis (universal) Dyspepsia H.
    [Show full text]
  • Helicobacter Spp. — Food- Or Waterborne Pathogens?
    FRI FOOD SAFETY REVIEWS Helicobacter spp. — Food- or Waterborne Pathogens? M. Ellin Doyle Food Research Institute University of Wisconsin–Madison Madison WI 53706 Contents34B Introduction....................................................................................................................................1 Virulence Factors ...........................................................................................................................2 Associated Diseases .......................................................................................................................2 Gastrointestinal Disease .........................................................................................................2 Neurological Disease..............................................................................................................3 Other Diseases........................................................................................................................4 Epidemiology.................................................................................................................................4 Prevalence..............................................................................................................................4 Transmission ..........................................................................................................................4 Summary .......................................................................................................................................5
    [Show full text]
  • Screening Practices for Infectious Diseases Among Burmese Refugees in Australia Nadia J
    Screening Practices for Infectious Diseases among Burmese Refugees in Australia Nadia J. Chaves,1 Katherine B. Gibney,1 Karin Leder, Daniel P. O’Brien, Caroline Marshall, and Beverley-Ann Biggs Increasing numbers of refugees from Burma (Myan- eases Service outpatient clinics at the Royal Melbourne mar) are resettling in Western countries. We performed a Hospital, Australia, during January 1, 2004–December retrospective study of 156 Burmese refugees at an Austra- 31, 2008. Patients were identifi ed through the hospital lian teaching hospital. Of those tested, Helicobacter pylori registration database, and medical, pathologic, radiolog- infection affected 80%, latent tuberculosis 70%, vitamin D ic, and pharmacologic records were reviewed. Screening defi ciency 37%, and strongyloidiasis 26%. Treating these tests audited included those suggested by the Australasian diseases can prevent long-term illness. Society for Infectious Diseases refugee screening guide- lines (5), along with vitamin D and hematologic studies. urma (Myanmar) has been the most common country These latter tests included full blood count, mean corpus- Bof origin for refugees who have recently resettled in cular volume, and platelet count. Investigations were per- the United States and Australia (1,2). Before resettling in formed at the discretion of the treating doctor, and not all Australia, most refugees undergo testing for HIV, have a tests were performed for each patient. Time was calculated chest radiograph to exclude active tuberculosis (TB), and from time of arrival in Australia to fi rst clinic attendance. may undergo other testing, depending on exposure risk. The results of serologic tests and QuantiFERON-TB Gold Many refugees also receive a health check and treatment tests (QFT-G; Cellestis Limited, Carnegie, Victoria, Aus- for malaria and stool parasites within 72 hours of departure tralia), were interpreted according to the manufacturers’ for Australia (3,4).
    [Show full text]
  • The Role of Helicobacter Spp. Infection in Domestic Animals
    Chapter 2 The Role of Helicobacter spp. Infection in Domestic Animals Achariya Sailasuta and Worapat Prachasilchai Additional information is available at the end of the chapter http://dx.doi.org/10.5772/53054 1. Introduction 1.1. Overview and pathogenesis The discovery of the association of Helicobacter pylori with chronic gastritis, peptic ulcers and gastric neoplasia, mucosa-associated lymphoid tissue-type lymphoma and carcinoma, has led to fundamental changes in the understanding of gastric disease in humans. Some hu‐ mans with H. pylori infection develop only mild, asymptomatic gastritis. Whether more se‐ vere disease develops thought to be influenced by individual host factors and pathogenicity of the bacteria involved. The odd of developing symptomatic H. pylori infection varies by geographic location and age. Different strains of H. pylori have recently been identified. Therefore, H. pylori should be considered a population of closely related but genetically het‐ erogenous bacteria of different genotypes and virulence. A gastric spiral bacteria of superkingdom bacteria, phylum proteobacteria, subphylum delta/epsilon subdivisions, class epsilonproteobacteria, order campylobacter, family helico‐ bacteraceae, genus Helicobacter spp. is gram-negative, spiral-shaped bacteria. At least 13 species have been reported, and most are suspected or proven gastric or hepatic patho‐ gens. Helicobacter spp. have been reported in humans: mainly H. pylori, nonhuman pri‐ mates: H. nemestrinae, cats and dogs various species, including H. pylori, H. felis, H. salomonis, H. rappini, H. heilmannii, and H. bizzozeronii, pigs: H. heilmannii, ferrets: H. muste‐ lae, and cheetahs: H. acinonys. More recently we have learned that nearly all mammmals harbor their own species of Helicobacter infection.
    [Show full text]
  • Lipopolysaccharide Modification in Gram-Negative Bacteria During Chronic Infection
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Queen's University Research Portal Lipopolysaccharide modification in Gram-negative bacteria during chronic infection Maldonado, R. F., Sá-Correia, I., & Valvano, M. (2016). Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol. Rev., 40(4), 480-493. DOI: 10.1093/femsre/fuw007 Published in: FEMS Microbiol. Rev. Document Version: Peer reviewed version Queen's University Belfast - Research Portal: Link to publication record in Queen's University Belfast Research Portal Publisher rights ©2016 Oxford University Press. This is a pre-copyedited, author-produced PDF of an article accepted for publication in FEMS Microbiology Reviews following peer review. The version of record is available online at: http://femsre.oxfordjournals.org/content/40/4/480 General rights Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the Research Portal that you believe breaches copyright or violates any law, please contact [email protected]. Download date:06. Nov. 2017 1 Lipopolysaccharide modification in Gram-negative bacteria during 2 chronic infection 3 4 Rita F.
    [Show full text]
  • Helicobacter Pylori-Derived Extracellular Vesicles Increased In
    OPEN Experimental & Molecular Medicine (2017) 49, e330; doi:10.1038/emm.2017.47 & 2017 KSBMB. All rights reserved 2092-6413/17 www.nature.com/emm ORIGINAL ARTICLE Helicobacter pylori-derived extracellular vesicles increased in the gastric juices of gastric adenocarcinoma patients and induced inflammation mainly via specific targeting of gastric epithelial cells Hyun-Il Choi1, Jun-Pyo Choi2, Jiwon Seo3, Beom Jin Kim3, Mina Rho4, Jin Kwan Han1 and Jae Gyu Kim3 Evidence indicates that Helicobacter pylori is the causative agent of chronic gastritis and perhaps gastric malignancy. Extracellular vesicles (EVs) play an important role in the evolutional process of malignancy due to their genetic material cargo. We aimed to evaluate the clinical significance and biological mechanism of H. pylori EVs on the pathogenesis of gastric malignancy. We performed 16S rDNA-based metagenomic analysis of gastric juices either from endoscopic or surgical patients. From each sample of gastric juices, the bacteria and EVs were isolated. We evaluated the role of H. pylori EVs on the development of gastric inflammation in vitro and in vivo. IVIS spectrum and confocal microscopy were used to examine the distribution of EVs. The metagenomic analyses of the bacteria and EVs showed that Helicobacter and Streptococcus are the two major bacterial genera, and they were significantly increased in abundance in gastric cancer (GC) patients. H. pylori EVs are spherical and contain CagA and VacA. They can induce the production of tumor necrosis factor-α, interleukin (IL)-6 and IL-1β by macrophages, and IL-8 by gastric epithelial cells. Also, EVs induce the expression of interferon gamma, IL-17 and EV-specific immunoglobulin Gs in vivo in mice.
    [Show full text]
  • What Is New in Helicobacter Pylori Diagnosis. an Overview
    Journal of Clinical Medicine Review What Is New in Helicobacter pylori Diagnosis. An Overview Maria Pina Dore 1,2,* and Giovanni Mario Pes 1 1 Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, University of Sassari, 07100 Sassari, Italy; [email protected] 2 Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA * Correspondence: [email protected]; Tel.: +39-079-229-886 Abstract: Helicobacter pylori infection remains one of the most prevalent infections worldwide, espe- cially in low-resource countries, and the major risk factor for peptic ulcer and gastric cancer. The “test-and-treat” strategy is recommended by several guidelines and consensus. The choice of testing method is based on patient age, presence of alarm signs and/or symptoms, use of non-steroidal anti-inflammatory drugs, as well as local availability, test reliability, and cost. Culture is the gold standard to detect H. pylori and, possibly, to perform susceptibility testing, however, it requires upper endoscopy and dedicated labs. Recent advances in molecular biology have provided new strategies in detecting infection and antimicrobial resistance without invasive tests. In this review we attempt to offer a comprehensive panorama on the new diagnostic tools and their potential use in clinical settings, in order to accomplish specific recommendations. Keywords: Helicobacter pylori; testing; antibiotic resistance; molecular techniques; artificial intelli- gence 1. Introduction Citation: Dore, M.P.; Pes, G.M. What Is New in Helicobacter pylori Helicobacter pylori infection can be essentially detected by invasive and non-invasive Diagnosis. An Overview. J. Clin. Med. tests. The choice of technique relies upon the patient’s needs.
    [Show full text]
  • Concomitant Infection of Helicobacter Pylori and Intestinal Parasites in Adults Attending a Referral Centre for Parasitic Infections in North Eastern Italy
    Journal of Clinical Medicine Article Concomitant Infection of Helicobacter pylori and Intestinal Parasites in Adults Attending a Referral Centre for Parasitic Infections in North Eastern Italy Elena Pomari 1,* , Tamara Ursini 1, Ronaldo Silva 1 , Martina Leonardi 1, Marco Ligozzi 2 and Andrea Angheben 1 1 Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy; [email protected] (T.U.); [email protected] (R.S.); [email protected] (M.L.); [email protected] (A.A.) 2 Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-04-5601-3111 Received: 23 June 2020; Accepted: 21 July 2020; Published: 24 July 2020 Abstract: Background: Helicobacter pylori and intestinal parasites are estimated to infect with high burden worldwide. However, their concomitant infections are poorly determined in industrialized countries, such as Italy. In this study we aim at describing the presence of H. pylori as well as the proportion of coinfections with intestinal parasites among subjects who attended a referral center for tropical diseases in Northern Italy. Methods: This was a case-control study. Screening for H. pylori and parasites was performed on stool samples of 93 adults from different geographical origin (Africa, Asia, South-America, East-Europe and Italy). H. pylori infection was examined by CLIA and its cagA positivity was determined by rtPCR. Intestinal parasites (i.e., protozoa and helminths) were examined by microscopy and rtPCR. Results: Sixty-one out of 93 patients (66%) were positive to H.
    [Show full text]
  • Spiral Bacteria in the Human Stomach: the Gastric Helicobacters Andre Dubois, M.D., Ph.D
    Synopses Spiral Bacteria in the Human Stomach: The Gastric Helicobacters Andre Dubois, M.D., Ph.D. Digestive Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA During the past decade, Helicobacter pylori has become recognized as one of the most common human pathogens, colonizing the gastric mucosa of almost all persons exposed to poor hygienic conditions from childhood. It also is often found, albeit with a lower frequency, in groups of high socioeconomic status. H. pylori causes chronic active gastritis and is a major factor in the pathogenesis of duodenal ulcers and, to a lesser extent, gastric ulcers. In addition, the presence of this bacterium is now recognized as a risk factor for gastric adenocarcinoma and lymphoma. Nevertheless, most infections appear without clinical consequences. In this second decade of intensive research, it is important to understand why H. pylori is sometimes a dangerous pathogen, and to determine how it can be eradicated in those at highest risk for severe disease. At the end of the 19th century, several types of Furthermore, in June 1994, the International spirochetes and spirilla were observed for the first Agency for Research on Cancer Working Group time in the stomach of animals (1,2). Beginning at stated , “H. pylori plays a causal role in the chain of the turn of the 20th century, similar spiral bacteria events leading to cancer,” referring to adenocarci- were found in gastrectomy specimens from patients noma and lymphoma of the stomach as well as to the with gastric cancer and peptic ulcer disease (3,4).
    [Show full text]